OBJECTIVE: The renal form of pseudohypoaldosteronism type 1 (PHA1) is a rare disease caused by mutations in the human mineralocorticoid receptor gene (NR3C2). DESIGN: Aim of the study was to analyze the NR3C2 gene in three Italian patients with clinical signs of renal PHA1 and to evaluate the distribution of the -2G > C, c.538A > G, and c.722C > T single nucleotide polymorphism (SNP) pattern in the PHA1 patients and in 90 controls of the same ethnic origin. METHODS: Analysis of the NR3C2 gene sequence and of the polymorphic SNP markers. Functional characterization of the detected novel NR3C2 mutations utilizing aldosterone-binding assays and reporter gene transactivation assays. RESULTS: One novel nonsense (Y134X) and one novel frameshift (2125delA) mutation were detected. They exhibited no aldosterone binding and no transactivation abilities. No mutation was detected in the third patient. Haploinsufficiency of NR3C2 was ruled out by microsatellite analysis in this patient. The c.722T SNP was detected in 97% of alleles in the Italian population which is significantly different from the general German or US population. CONCLUSIONS: Molecular analysis of the NR3C2 gene in PHA1 patients is warranted to detect novel mutations in order to clarify the underlying genetic cause, which may extend the insight into relevant functional regions of the hMR protein. The effect the different distribution of the c.722T SNP is not clear to date. Further studies are necessary to provide evidence as to a possible advantage of a less sensitive hMR in southern countries.
OBJECTIVE: The renal form of pseudohypoaldosteronism type 1 (PHA1) is a rare disease caused by mutations in the humanmineralocorticoid receptor gene (NR3C2). DESIGN: Aim of the study was to analyze the NR3C2 gene in three Italian patients with clinical signs of renal PHA1 and to evaluate the distribution of the -2G > C, c.538A > G, and c.722C > T single nucleotide polymorphism (SNP) pattern in the PHA1patients and in 90 controls of the same ethnic origin. METHODS: Analysis of the NR3C2 gene sequence and of the polymorphic SNP markers. Functional characterization of the detected novel NR3C2 mutations utilizing aldosterone-binding assays and reporter gene transactivation assays. RESULTS: One novel nonsense (Y134X) and one novel frameshift (2125delA) mutation were detected. They exhibited no aldosterone binding and no transactivation abilities. No mutation was detected in the third patient. Haploinsufficiency of NR3C2 was ruled out by microsatellite analysis in this patient. The c.722T SNP was detected in 97% of alleles in the Italian population which is significantly different from the general German or US population. CONCLUSIONS: Molecular analysis of the NR3C2 gene in PHA1patients is warranted to detect novel mutations in order to clarify the underlying genetic cause, which may extend the insight into relevant functional regions of the hMR protein. The effect the different distribution of the c.722T SNP is not clear to date. Further studies are necessary to provide evidence as to a possible advantage of a less sensitive hMR in southern countries.
Authors: Dimas Yusuf; Stefanie L Butland; Magdalena I Swanson; Eugene Bolotin; Amy Ticoll; Warren A Cheung; Xiao Yu Cindy Zhang; Christopher T D Dickman; Debra L Fulton; Jonathan S Lim; Jake M Schnabl; Oscar H P Ramos; Mireille Vasseur-Cognet; Charles N de Leeuw; Elizabeth M Simpson; Gerhart U Ryffel; Eric W-F Lam; Ralf Kist; Miranda S C Wilson; Raquel Marco-Ferreres; Jan J Brosens; Leonardo L Beccari; Paola Bovolenta; Bérénice A Benayoun; Lara J Monteiro; Helma D C Schwenen; Lars Grontved; Elizabeth Wederell; Susanne Mandrup; Reiner A Veitia; Harini Chakravarthy; Pamela A Hoodless; M Michela Mancarelli; Bruce E Torbett; Alison H Banham; Sekhar P Reddy; Rebecca L Cullum; Michaela Liedtke; Mario P Tschan; Michelle Vaz; Angie Rizzino; Mariastella Zannini; Seth Frietze; Peggy J Farnham; Astrid Eijkelenboom; Philip J Brown; David Laperrière; Dominique Leprince; Tiziana de Cristofaro; Kelly L Prince; Marrit Putker; Luis del Peso; Gieri Camenisch; Roland H Wenger; Michal Mikula; Marieke Rozendaal; Sylvie Mader; Jerzy Ostrowski; Simon J Rhodes; Capucine Van Rechem; Gaylor Boulay; Sam W Z Olechnowicz; Mary B Breslin; Michael S Lan; Kyster K Nanan; Michael Wegner; Juan Hou; Rachel D Mullen; Stephanie C Colvin; Peter John Noy; Carol F Webb; Matthew E Witek; Scott Ferrell; Juliet M Daniel; Jason Park; Scott A Waldman; Daniel J Peet; Michael Taggart; Padma-Sheela Jayaraman; Julien J Karrich; Bianca Blom; Farhad Vesuna; Henriette O'Geen; Yunfu Sun; Richard M Gronostajski; Mark W Woodcroft; Margaret R Hough; Edwin Chen; G Nicholas Europe-Finner; Magdalena Karolczak-Bayatti; Jarrod Bailey; Oliver Hankinson; Venu Raman; David P LeBrun; Shyam Biswal; Christopher J Harvey; Jason P DeBruyne; John B Hogenesch; Robert F Hevner; Christophe Héligon; Xin M Luo; Marissa Cathleen Blank; Kathleen Joyce Millen; David S Sharlin; Douglas Forrest; Karin Dahlman-Wright; Chunyan Zhao; Yuriko Mishima; Satrajit Sinha; Rumela Chakrabarti; Elodie Portales-Casamar; Frances M Sladek; Philip H Bradley; Wyeth W Wasserman Journal: Genome Biol Date: 2012 Impact factor: 13.583
Authors: Balazs Duga; Marta Czako; Katalin Komlosi; Kinga Hadzsiev; Katalin Torok; Katalin Sumegi; Peter Kisfali; Gyorgy Kosztolanyi; Bela Melegh Journal: Mol Cytogenet Date: 2014-06-05 Impact factor: 2.009